NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Pacific Biosciences (NQ: PACB)
6.910 USD  -0.050 (-0.72%)
Official Closing Price  /  Updated: 5:21 PM EDT, May 23, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,946,628
Open 6.940
Bid (Size) 6.850 (2)
Ask (Size) 7.160 (2)
Prev. Close 6.960
Today's Range 6.900 - 6.960
52wk Range 2.480 - 7.840
Shares Outstanding 131,876,642
Dividend Yield N/A
Performance
YTD
-6.62%
-6.62%
1 Month
-5.47%
-5.47%
3 Month
-4.95%
-4.95%
6 Month
-7.50%
-7.50%
1 Year
+164.75%
+164.75%
Top News
More News
Pacific Biosciences of California, Inc. Announces First Quarter 2019 Financial Results
Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2019, as attached. Read More
from GlobeNewswire News Releases
Pacific Biosciences Launches New Sequel II System, Featuring ~8 Times the DNA Sequencing Data Output
Pacific Biosciences of California Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced the commercial launch of the Sequel® II... Read More
from GlobeNewswire News Releases
More News
Read More
Transplant Matches Identified by Ultra-High-Resolution HLA Typing Associated with Higher Patient Survival Rates
from GlobeNewswire News Releases
Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT Conference
from GlobeNewswire News Releases
Pacific Biosciences Announces Fourth Quarter and Annual 2018 Financial Results
from GlobeNewswire News Releases
Report: Exploring Fundamental Drivers Behind SkyWest, Pacific Biosciences of California, Lennar, Regeneron Pharmaceuticals, MGM Growth Properties, and Cincinnati Bell — New Horizons, Emerging Trends,
from GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Red Hat, LSC Communications, Intersections, and Pacific Biosciences on Behalf of Stockholders and Enco
from GlobeNewswire News Releases
Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action complaint in the United States District Court for the Northern District of California on behalf of holders of Pac
from GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Pacific Biosciences of California, Inc. (PACB) on Behalf of Stockholders and Encourages PACB Investors to Contact the Firm
from GlobeNewswire News Releases
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB
from PR Newswire
3 Top Healthcare Stocks to Buy Right Now
category PACB , HRTX , ILMN , and 2 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.